Skip to content

Effects of acupuncture in the treatment of age-related reduced fertility in women

A randomized controlled trial of acupuncture in the treatment of age-related reduced fertility in women

Status
Active, not recruiting
Phases
Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400086376
Enrollment
Unknown
Registered
2024-07-01
Start date
2024-07-15
Completion date
Unknown
Last updated
2024-07-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Age-related fertility decline in women

Interventions

acupuncture group:acupuncture treatment

Sponsors

Sichuan Jinxin Xinan Women's and Children's Hospital
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
30 Years to 45 Years

Inclusion criteria

Inclusion criteria: (1) Age: 30= age =45 years, female; (2) Those who met both the DOR diagnostic criteria and those who were classified as having poor ovarian reserve function (=75 points) by the AAFA model of the OvaRePred prediction tool; (3) Regular menstrual cycle, i.e. (28±7) days; (4) Not participating in other ongoing clinical studies and not receiving acupuncture treatment targeting infertility in the last 3 months; (5) Informed consent signed by the patient herself or signed by her immediate family members on her behalf. Note: Subjects who also met the above 5 criteria were eligible for inclusion in this study.

Exclusion criteria

Exclusion criteria: (1) DOR caused by medical factors, such as pelvic surgery, radiotherapy or chemotherapy, uterine artery embolization, hormonal or immunosuppressive drugs; (2) Combination of other endocrine diseases that may affect reproductive function, such as polycystic ovary syndrome, hyperprolactinemia, hyperandrogenic individuals, thyroid disease, diabetes mellitus; (3) Combined with serious cardiovascular, cerebrovascular, hepatic, renal, malignant tumor, hematopoietic system diseases; (4) Combined with any mental illness; (5) Patients or partners with chromosomal abnormalities; (6) Patients with bleeding tendency and susceptibility to infection, or patients suffering from severe allergic diseases, or patients with skin ulcers or scarring that prohibit needling. (7) Those who are expected to have an in vitro program within 3 months of enrollment; Note: Any patient who meets any of the above criteria will be excluded.

Design outcomes

Primary

MeasureTime frame
Scores and grading of the AAFA model, AFA model, and AA model in the Ovarian Reserve Assessment Calculator (OvaRePred).;

Secondary

MeasureTime frame
Self-Rating Anxiety Scale (SAS);Self-Rating Depression Scale (SDS);AMH;Serum sex hormone levels(FSH,E2,LH,P);

Countries

China

Contacts

Public ContactYang Jie

Chengdu University of TCM;Sichuan Jinxin Xinan Women's and Children's Hospital

jenny_yang_jie@126.com+86 138 8229 6714

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026